MarginsXMarginsX
Home › Canada › CSE stocks › SNDL

SNDL Inc. (CSE: SNDL)

SNDL trades on the Canadian Securities Exchange in Life Sciences. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$1.94
-2.51% on the day
Market cap (C$)
C$510.9M
TMX list, November 16, 2026
Market cap (US$)
US$358.4M
Small cap at 1.4257 C$/US$
1-year return
-18.5%
-14.2% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 16, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for SNDL.CN, last bar 2026-11-13, computed by MarginsX. Website: sociallinks: 40-F text ("our website").

Profile

FieldValue
TickerSNDL on the Canadian Securities Exchange
Yahoo symbolSNDL.CN
SectorLife Sciences
HeadquartersThe TMX list gives no head office
ListedThe TMX list gives no listing date
Listing typeTMX leaves listing type blank for long-listed issuers
Shares outstanding263,359,123
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIK0001766600
Websitewww.sndl.com
US listingSNDL

Returns

WindowReturn
1 day-2.5%
1 week-2.0%
1 month+16.2%
3 months+7.8%
6 months+0.5%
Year to date-14.2%
1 year-18.5%
From 52-week high-36.4%
52-week rangeC$1.62 to C$3.05

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

105 documents in 12 types. Each title links to the document at its source.

Annual financial statements (2)

Interim financial statements (7)

MD&A (9)

DocumentTypeFiled
Management’s Discussion and Analysis of the Company for the year ended December 31, 2025
Period 2025-12-31
MD&A (annual) (40-F)2026-03-12
2023 MD&A
Period 2024-12-31
MD&A (annual) (40-F)2025-03-18
Management’s Discussion and Analysis for the Three and Nine Months Ended September 30, 2026
Period 2026-09-30
MD&A (interim) (6-K)2026-10-27
Management’s Discussion and Analysis for the Three and Six Months Ended June 30, 2026
Period 2026-06-30
MD&A (interim) (6-K)2026-07-28

Annual information form (2)

DocumentTypeFiled
Annual Information Form of the Company for the year ended December 31, 2025
Period 2025-12-31
Annual information form (40-F)2026-03-12
2023 AIF
Period 2024-12-31
Annual information form (40-F)2025-03-18

Material change report (2)

DocumentTypeFiled
MATERIAL CHANGE REPORTMaterial change report (6-K)2025-04-17
MATERIAL CHANGE REPORTMaterial change report (6-K)2024-10-23

News release (35)

DocumentTypeFiled
PRESS RELEASENews release (6-K)2026-10-27
PRESS RELEASENews release (6-K)2026-10-15
PRESS RELEASENews release (6-K)2026-10-14
PRESS RELEASENews release (6-K)2026-10-06

Management information circular / proxy (6)

DocumentTypeFiled
to this report on Form 6-K shall be deemed to be incorporated by reference in SNDL Inc.’s
Period 2025-12-31
Notice of meeting (6-K)2026-09-08
Notice and Access NotificationNotice of meeting (6-K)2026-09-08
to this report on Form 6-K shall be deemed to be incorporated by reference in SNDL Inc.’s
Period 2024-12-31
Notice of meeting (6-K)2025-06-20
Notice-and-Access Notice
Period 2024-12-31
Notice of meeting (6-K)2025-06-20

Annual report (2)

DocumentTypeFiled
40-F
Period 2025-12-31
Annual report (40-F) (40-F)2026-03-12
40-F
Period 2024-12-31
Annual report (40-F) (40-F)2025-03-18

Early warning / ownership (3)

DocumentTypeFiled
Schedule 13G amendmentSchedule 13G (SCHEDULE 13G/A)2025-08-20
Schedule 13GSchedule 13G (SCHEDULE 13G)2025-08-14
EARLY WARNING REPORTEarly warning report (6-K)2024-10-23

Insider report (3)

DocumentTypeFiled
Form 144Form 144 (144)2025-12-12
Form 144Form 144 (144)2025-12-12
Form 144Form 144 (144)2025-12-12

Certification (22)

Other (12)

DocumentTypeFiled
Consent of Independent Registered Public Accounting Firm
Period 2025-12-31
Consent (40-F)2026-03-12
Consent of Independent Registered Public Accounting Firm
Period 2025-12-31
Consent (40-F)2026-03-12
AUDITOR CONSENT
Period 2024-12-31
Consent (40-F)2025-03-18
ARRANGEMENT AGREEMENTMaterial contract / governance (6-K)2025-04-17

Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

No CIRO halt notices for this company in our data.

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Recent

DateTimeEventWebcastSource
2026-10-2710:00 a.m. EDTQ3 2026 earnings callWebcastSEC filing
2026-10-27before markets openQ3 2026 earnings releaseNo webcast link announcedSEC filing

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

US private placements (SEC Form D)

FiledSecuritiesSoldOfferedFiling
2019-05-24DebtUS$40.7MUS$45.7MSEC EDGAR

Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
VREOVireo Growth Inc.CSEC$502.1M-30.7%-60.9%
FRXFennec Pharmaceuticals Inc.TSXC$522.2M+14.3%+50.8%
EPRXEupraxia Pharmaceuticals Inc.TSXC$640.1M+21.5%+32.7%
WEEDCanopy Growth CorporationTSXC$393.7M-25.0%-47.1%
ACBAurora Cannabis Inc.TSXC$372.0M+15.4%+14.4%

The app has the price chart, every filing, private raises and the full peer set for SNDL.

Open in the app